(Q41157469)

27 September 2017

title

Genotoxic drugs induce interaction of the c-Abl tyrosine kinase and the tumor suppressor protein p53. (English)

1 reference

27 September 2017

1 reference

Yuan ZM

1

1 reference

27 September 2017

Huang Y

2

1 reference

27 September 2017

Fan MM

3

1 reference

27 September 2017

Sawyers C

4

1 reference

27 September 2017

Kharbanda S

5

1 reference

27 September 2017

Kufe D

6

1 reference

27 September 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

Journal of Biological Chemistry

27 September 2017

published in

1 reference

27 September 2017

volume

271

1 reference

27 September 2017

issue

43

1 reference

27 September 2017

page(s)

26457-26460

1 reference

Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

The stress response to ionizing radiation involoves c-Abl-dependent phosphorylation of SHPTP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

Src homology 2 domain as a specificity determinant in the c-Abl-mediated tyrosine phosphorylation of the RNA polymerase II carboxyl-terminal repeated domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

The nuclear tyrosine kinase c-Abl negatively regulates cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

Differential phosphorylation of c-Abl in cell cycle determined by cdc2 kinase and phosphatase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

Potentiation of alkylation-induced sister chromatid exchange frequency by 3-aminobenzamide is mediated by intracellular loss of NAD .

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

Role for c-Abl tyrosine kinase in growth arrest response to DNA damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

c-Abl activation regulates induction of the SEK1/stress-activated protein kinase pathway in the cellular response to 1-beta-D-arabinofuranosylcytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

Inhibition of cyclin-dependent kinases by p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

Radiation-induced cell cycle arrest compromised by p21 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074/JBC.271.43.26457

21 January 2018

Identifiers

DOI

10.1074/JBC.271.43.26457

1 reference

27 September 2017

1 reference